Replies to post #545552 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Are you sure? This doesn’t look too complicated:


https://clinicaltrials.gov/ct2/show/NCT04201873

[exwannabe]

It I’d highly unlikely this p1 would qualify as a registration trial . Remember also it is a combo trial that makes analysis and interpretation more complicated.

The principal investigator stated the trial is not designed to establish efficacy.

It cannot establish that ATL-DC adds anything to neo adjuvant PD-L1 + Poly ICLC+PD-L1 as that is not one of the arms.